| Liver Macrophages: Old Dogmas and New Insights |
40 |
| Risk for Development of Severe Liver Disease in Lean Patients With Nonalcoholic Fatty Liver Disease: A Long-Term Follow-Up Study |
31 |
| Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease |
28 |
| Natural History of Nonalcoholic Fatty Liver Disease: A Prospective Follow-Up Study With Serial Biopsies |
21 |
| Endothelial Wnts Regulate beta-Catenin Signaling in Murine Liver Zonation and Regeneration: A Sequel to the Wnt-Wnt Situation |
20 |
| Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct Acting Antivirals for Hepatitis C |
18 |
| Liver Tissue Engineering: From Implantable Tissue to Whole Organ Engineering |
18 |
| FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice |
16 |
| Acute Hepatic Porphyrias: Review and Recent Progress |
15 |
| Tropifexor-Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents |
15 |
| Metabolomic-Based Noninvasive Serum Test to Diagnose Nonalcoholic Steatohepatitis: Results From Discovery and Validation Cohorts |
15 |
| Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship |
15 |
| NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double Blind Placebo Controlled Trial |
15 |
| Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States |
15 |
| Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein Cholesterol |
14 |
| L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis |
13 |
| Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome |
13 |
| Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout Mice |
13 |
| Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis |
12 |
| Molecular Magnetic Resonance Imaging Accurately Measures the Antifibrotic Effect of EDP-305 a Novel Farnesoid X Receptor Agonist |
12 |
| High-Mobility Group Box-1 and Liver Disease |
12 |
| Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis |
12 |
| Quantitative Assessment of Liver Fibrosis Reveals a Nonlinear Association With Fibrosis Stage in Nonalcoholic Fatty Liver Disease |
11 |
| IL-22 and IL-22-Binding Protein Are Associated With Development of and Mortality From Acute-on-Chronic Liver Failure |
11 |
| A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At Risk Populations in Primary Care |
11 |
| Protein Phosphatase 1 Regulatory Subunit 3B Gene Variation Protects Against Hepatic Fat Accumulation and Fibrosis in Individuals at High Risk of Nonalcoholic Fatty Liver Disease |
11 |
| Telomerase Reverse Transcriptase Mutations in Plasma DNA in Patients With Hepatocellular Carcinoma or Cirrhosis: Prevalence and Risk Factors |
11 |
| Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans |
11 |
| Incidence and Cost Analysis of Hospital Admission and 30-Day Readmission Among Patients With Cirrhosis |
10 |
| Outcomes of Pregnancy in Mothers With Cirrhosis: A National Population-Based Cohort Study of 1.3 Million Pregnancies |
10 |
| Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial |
10 |
| Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis |
10 |
| Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes |
10 |
| Hepatitis B Treatment: What We Know Now and What Remains to Be Researched |
10 |
| Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis |
10 |
| A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis |
10 |
| Genotype 5 Hepatitis E Virus Produced by a Reverse Genetics System Has the Potential for Zoonotic Infection |
10 |
| Pyrroloquinoline Quinone Prevents Developmental Programming of Microbial Dysbiosis and Macrophage Polarization to Attenuate Liver Fibrosis in Offspring of Obese Mice |
9 |
| A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice |
9 |
| Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care |
9 |
| Association of Hepatic Steatosis With Subclinical Atherosclerosis: Systematic Review and Meta-Analysis |
9 |
| Patatin-Like Phospholipase Domain Containing 3 Variants Differentially Impact Metabolic Traits in Individuals at High Risk for Cardiovascular Events |
9 |
| Adipose-Specific Lipin-1 Overexpression Renders Hepatic Ferroptosis and Exacerbates Alcoholic Steatohepatitis in Mice |
9 |
| Neutrophils Alleviate Fibrosis in the CCl4-Induced Mouse Chronic Liver Injury Model |
9 |
| Acute Decompensation Boosts Hepatic Collagen Type III Deposition and Deteriorates Experimental and Human Cirrhosis |
8 |
| Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy |
8 |
| Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease |
8 |
| Serum Interleukin- Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease |
8 |
| Medication-Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention |
8 |
| Hepatitis E Virus Replication and Interferon Responses in Human Placental Cells |
8 |
